{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T03:40:04Z","timestamp":1751514004688,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"DOI":"10.7759\/cureus.87193","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T03:23:16Z","timestamp":1751512996000},"source":"Crossref","is-referenced-by-count":0,"title":["Dyslipidemia Associated With Type 2 Diabetes Mellitus as a Strong Predictor of ICU Admission in COVID-19 Patients: A Retrospective Comparative Study"],"prefix":"10.7759","author":[{"given":"Abdurahman","family":"Alfaiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad D","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feras","family":"Almarshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muath A","family":"Alammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeeshan","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7461","article-title":"A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions","volume":"36","author":"Pawar A","year":"2022","unstructured":"Pawar A, Russo M, Rani I, Goswami K, Russo GL, Pal A. A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions. Phytother Res. 2022, 36:2394-415. 10.1002\/ptr.7461","journal-title":"Phytother Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02194-22","article-title":"Integrated metabolic and inflammatory signatures associated with severity of, fatality of, and recovery from COVID-19","volume":"11","author":"Gardinassi LG","year":"2023","unstructured":"Gardinassi LG, Servian CD, Lima GD, et al.. Integrated metabolic and inflammatory signatures associated with severity of, fatality of, and recovery from COVID-19. Microbiol Spectr. 2023, 11:e0219422. 10.1128\/spectrum.02194-22","journal-title":"Microbiol Spectr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13085","article-title":"Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes","volume":"12","author":"Rajpal A","year":"2020","unstructured":"Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020, 12:895-908. 10.1111\/1753-0407.13085","journal-title":"J Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27438","article-title":"A review of COVID-19 in relation to metabolic syndrome: obesity, hypertension, diabetes, and dyslipidemia","volume":"14","author":"Makhoul E","year":"2022","unstructured":"Makhoul E, Aklinski JL, Miller J, et al.. A review of COVID-19 in relation to metabolic syndrome: obesity, hypertension, diabetes, and dyslipidemia. Cureus. 2022, 14:e27438. 10.7759\/cureus.27438","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.05.017","article-title":"Clinical characteristics and outcomes of type 2 diabetes patients infected with COVID-19: a retrospective study","volume":"6","author":"Chen Y","year":"2020","unstructured":"Chen Y, Chen J, Gong X, et al.. Clinical characteristics and outcomes of type 2 diabetes patients infected with COVID-19: a retrospective study. Engineering (Beijing). 2020, 6:1170-7. 10.1016\/j.eng.2020.05.017","journal-title":"Engineering (Beijing)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1340","article-title":"mpact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in Lombardy, Italy","volume":"43","author":"Mirani M","year":"2020","unstructured":"Mirani M, Favacchio G, Carrone F, et al.. mpact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in Lombardy, Italy. Diabetes Care. 2020, 43:3042-9. 10.2337\/dc20-1340","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3377","article-title":"Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)","volume":"37","author":"Zhou Y","year":"2021","unstructured":"Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021, 37:e3377. 10.1002\/dmrr.3377","journal-title":"Diabetes Metab Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166559","article-title":"Molecular and pro-inflammatory aspects of COVID-19: the impact on cardiometabolic health","volume":"1868","author":"Lo Presti E","year":"2022","unstructured":"Lo Presti E, Nuzzo D, Al Mahmeed W, et al.. Molecular and pro-inflammatory aspects of COVID-19: the impact on cardiometabolic health. Biochim Biophys Acta Mol Basis Dis. 2022, 1868:166559. 10.1016\/j.bbadis.2022.166559","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9061211","article-title":"Type-2 diabetes as a risk factor for severe COVID-19 infection","volume":"9","author":"Norouzi M","year":"2021","unstructured":"Norouzi M, Norouzi S, Ruggiero A, Khan MS, Myers S, Kavanagh K, Vemuri R. Type-2 diabetes as a risk factor for severe COVID-19 infection. Microorganisms. 2021, 9:1211. 10.3390\/microorganisms9061211","journal-title":"Microorganisms"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-022-00887-4","article-title":"Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review","volume":"78","author":"Moreno-Fernandez J","year":"2022","unstructured":"Moreno-Fernandez J, Ochoa J, Ojeda ML, Nogales F, Carreras O, D\u00edaz-Castro J. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review. J Physiol Biochem. 2022, 78:581-91. 10.1007\/s13105-022-00887-4","journal-title":"J Physiol Biochem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26102834","article-title":"Role of resveratrol in prevention and control of cardiovascular disorders and cardiovascular complications related to COVID-19 disease: mode of action and approaches explored to increase its bioavailability","volume":"26","author":"Gligorijevi\u0107 N","year":"2021","unstructured":"Gligorijevi\u0107 N, Stani\u0107-Vu\u010dini\u0107 D, Radomirovi\u0107 M, Stojadinovi\u0107 M, Khulal U, Nedi\u0107 O, \u0106irkovi\u0107 Veli\u010dkovi\u0107 T. Role of resveratrol in prevention and control of cardiovascular disorders and cardiovascular complications related to COVID-19 disease: mode of action and approaches explored to increase its bioavailability. Molecules. 2021, 26:2834. 10.3390\/molecules26102834","journal-title":"Molecules"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jegh.2015.07.004","article-title":"Cardiovascular risk profiles of adults with type-2 diabetes treated at urban hospitals in Riyadh, Saudi Arabia","volume":"6","author":"Al Slail FY","year":"2016","unstructured":"Al Slail FY, Abid O, Assiri AM, Memish ZA, Ali MK. Cardiovascular risk profiles of adults with type-2 diabetes treated at urban hospitals in Riyadh, Saudi Arabia. J Epidemiol Glob Health. 2016, 6:29-36. 10.1016\/j.jegh.2015.07.004","journal-title":"J Epidemiol Glob Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4236\/ojemd.2012.24014","article-title":"Prevalence and correlates of dyslipidemia among adults in Saudi Arabia: results from a national survey","volume":"2","author":"Al-Kaabba AF","year":"2012","unstructured":"Al-Kaabba AF, Al-Hamdan NA, El Tahir A, Abdalla AM, Saeed AA, Hamza MA. Prevalence and correlates of dyslipidemia among adults in Saudi Arabia: results from a national survey. Open J Endocr Metab Dis. 2012, 2:89-97. 10.4236\/ojemd.2012.24014","journal-title":"Open J Endocr Metab Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S235546","article-title":"Association of dyslipidemia and comorbidities with risk factors among diabetic patients: a retrospective analysis","volume":"13","author":"Gazzaz ZJ","year":"2020","unstructured":"Gazzaz ZJ, Iftikhar R, Jameel T, Baig M, Murad MA. Association of dyslipidemia and comorbidities with risk factors among diabetic patients: a retrospective analysis. Diabetes Metab Syndr Obes. 2020, 13:935-41. 10.2147\/DMSO.S235546","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen MR","year":"2015","unstructured":"Taskinen MR, Bor\u00e9n J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015, 239:483-95. 10.1016\/j.atherosclerosis.2015.01.039","journal-title":"Atherosclerosis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0023-5","article-title":"Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management","volume":"73","author":"Chehade JM","year":"2013","unstructured":"Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs. 2013, 73:327-39. 10.1007\/s40265-013-0023-5","journal-title":"Drugs"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102231","article-title":"COVID-19 among people with diabetes mellitus in Saudi Arabia: current situation and new perspectives","volume":"15","author":"Robert AA","year":"2021","unstructured":"Robert AA, Al Saeed A, Al Dawish MA. COVID-19 among people with diabetes mellitus in Saudi Arabia: current situation and new perspectives. Diabetes Metab Syndr. 2021, 15:102231. 10.1016\/j.dsx.2021.102231","journal-title":"Diabetes Metab Syndr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108538","article-title":"Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh, Saudi Arabia","volume":"172","author":"Sheshah E","year":"2021","unstructured":"Sheshah E, Sabico S, Albakr RM, et al.. Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh, Saudi Arabia. Diabetes Res Clin Pract. 2021, 172:108538. 10.1016\/j.diabres.2020.108538","journal-title":"Diabetes Res Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.12.023","article-title":"Outcome of SARS CoV-2 inpatients treated with convalescent plasma: one-year of data from the Veneto region (Italy) Registry","volume":"97","author":"De Silvestro G","year":"2022","unstructured":"De Silvestro G, Marson P, La Raja M, et al.. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: one-year of data from the Veneto region (Italy) Registry. Eur J Intern Med. 2022, 97:42-9. 10.1016\/j.ejim.2021.12.023","journal-title":"Eur J Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-012-0760-9","article-title":"Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism","volume":"18","author":"Adedayo AM","year":"2014","unstructured":"Adedayo AM, Olafiranye O, Smith D, Hill A, Zizi F, Brown C, Jean-Louis G. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath. 2014, 18:13-8. 10.1007\/s11325-012-0760-9","journal-title":"Sleep Breath"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2838","article-title":"Atherogenic dyslipidemia on admission is associated with poorer outcome in people with and without diabetes hospitalized for COVID-19","volume":"44","author":"Bellia A","year":"2021","unstructured":"Bellia A, Andreadi A, Giudice L, et al.. Atherogenic dyslipidemia on admission is associated with poorer outcome in people with and without diabetes hospitalized for COVID-19. Diabetes Care. 2021, 44:2149-57. 10.2337\/dc20-2838","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.10.012","article-title":"The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients","volume":"14","author":"Alamdari NM","year":"2020","unstructured":"Alamdari NM, Rahimi FS, Afaghi S, et al.. The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients. Diabetes Metab Syndr. 2020, 14:1979-86. 10.1016\/j.dsx.2020.10.012","journal-title":"Diabetes Metab Syndr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383609-dyslipidemia-associated-with-type-2-diabetes-mellitus-as-a-strong-predictor-of-icu-admission-in-covid-19-patients-a-retrospective-comparative-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T03:23:17Z","timestamp":1751512997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383609-dyslipidemia-associated-with-type-2-diabetes-mellitus-as-a-strong-predictor-of-icu-admission-in-covid-19-patients-a-retrospective-comparative-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.87193","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}